MDRNA to sell calcitonin-salmon nasal spray assets to Par Pharmaceutical - MarketLine Financial Deals

MDRNA to sell calcitonin-salmon nasal spray assets to Par Pharmaceutical

MDRNA to sell calcitonin-salmon nasal spray assets to Par Pharmaceutical - MarketLine Financial Deals
MDRNA to sell calcitonin-salmon nasal spray assets to Par Pharmaceutical
Published Apr 01, 2009
2 pages — Published Apr 01, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

MDRNA, Inc., a biotechnology company, has entered into an asset purchase agreement to sell certain assets related to a nasal spray drug for osteoporosis to Par Pharmaceutical Companies, Inc., a manufacturer and marketer of generic and branded pharmaceuticals.

  
Source:
Document ID
MA02912_090403
Country
Ticker
MRNA=US
Ticker
PRX=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "MDRNA to sell calcitonin-salmon nasal spray assets to Par Pharmaceutical" Apr 01, 2009. Alacra Store. Dec 05, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/MDRNA-to-sell-calcitonin-salmon-nasal-spray-assets-to-Par-Pharmaceutical-2052-2795>
  
APA:
MarketLine Financial Deals. (2009). MDRNA to sell calcitonin-salmon nasal spray assets to Par Pharmaceutical Apr 01, 2009. New York, NY: Alacra Store. Retrieved Dec 05, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/MDRNA-to-sell-calcitonin-salmon-nasal-spray-assets-to-Par-Pharmaceutical-2052-2795>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.